Protagen Diagnostics Overview

  • Founded
  • 1997
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 32
Employees
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $1.95M
Latest Deal Amount
  • Investors
  • 1

Protagen Diagnostics General Information

Description

Developer of diagnostic tests designed to provide treatment of autoimmune diseases. The company's biomarker discovery platform is used for the detection of autoantibodies in individuals undergoing cancer immunotherapy, as a means of predicting treatment response and guiding therapeutic decisions, enabling patients to begin treatment more quickly and result in a higher likelihood of successful treatment.

Contact Information

Website
www.protagen.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Diagnostic Equipment
Other Industries
Therapeutic Devices
Drug Discovery
Parent Company
Oncimmune
Primary Office
  • Otto-Hahn-Street 15
  • 44227 Dortmund
  • Germany
+49 0231 00000000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Protagen Diagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Merger/Acquisition 19-Mar-2019 $1.95M 000.00 00.000 Completed Generating Revenue
7. Later Stage VC 19-Jan-2015 00.000 000.00 Completed Generating Revenue
6. Later Stage VC 07-Oct-2010 000.00 000.00 Completed Generating Revenue
5. Later Stage VC 03-Aug-2009 00.000 0000 Completed Generating Revenue
4. Later Stage VC 01-Aug-2008 00.00 Completed Generating Revenue
3. Later Stage VC 15-Jan-2008 00.000 00.00 Completed Generating Revenue
2. Later Stage VC 08-May-2006 $4.1M $5.34M Completed Generating Revenue
1. Later Stage VC 01-Jan-2004 $1.24M $1.24M Completed Generating Revenue
To view Protagen Diagnostics’s complete valuation and funding history, request access »

Protagen Diagnostics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of diagnostic tests designed to provide treatment of autoimmune diseases. The company's biomarker discovery pl
Diagnostic Equipment
Dortmund, Germany
32 As of 2006
000.00
0.000 0000-00-00
000000&0 000.00

0000000

trud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in
00000 0000000000 0000000000 0000000
Gosselies, Belgium
00 As of 0000
000.00
00.00 0000-00-00
00000000000 000.00

00000000

ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolo
0000000000000
Gaithersburg, MD
00 As of 0000
000.00
000 0000-00-00
00000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Protagen Diagnostics Competitors (9)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
OncoDNA Venture Capital-Backed Gosselies, Belgium 00 000.00 00000000000 000.00
000000000 Venture Capital-Backed Gaithersburg, MD 00 000.00 00000000000 000.00
000000 Venture Capital-Backed Seattle, WA 00 000.00 0000000000 0 000.00
0000 00000000000 Venture Capital-Backed Cambridge, MA 00 00000 00000000000 00000
0000000 0000000000 Venture Capital-Backed Diepenbeek, Belgium 0 000.00 00000000000 000.00
You’re viewing 5 of 9 competitors. Get the full list »

Protagen Diagnostics Executive Team (8)

Name Title Board Seat Contact Info
Petra Budde Head, Medical Research
Hans-Dieter Zucht Head, Technology
Peter Schulz-Knappe MD Chief Scientific Officer
You’re viewing 3 of 8 executive team members. Get the full list »

Protagen Diagnostics Board Members (12)

Name Representing Role Since
Bernhard Kirschbaum Ph.D Protagen Diagnostics Chairman 000 0000
Dirk Ehlers Ph.D Self Board Member 000 0000
Martin Bluggel Self Board Member 000 0000
Matthias Guth Protagen Diagnostics Board Member 000 0000
Oliver Schacht Ph.D Self Board Member 000 0000
You’re viewing 5 of 12 board members. Get the full list »

Protagen Diagnostics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Protagen Diagnostics Former Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Dusseldorf (site) Corporation Minority 000 0000 000000 0
KfW Group Investment Bank Minority 000 0000 000000 0
MIG AG Venture Capital Minority 000 0000 000000 0
Munich Re Corporation Minority 000 0000 000000 0
NRW.Bank Investment Bank Minority 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »

Ready to get started?

Request a free trial